ADA, antidrug antibodies; ERT, enzyme replacement therapy; FD, Fabry disease Full size image How would you characterize the severity of your Fabry disease symptoms? Multiple choice: mild-moderate symptoms; bothersome symptoms; symptoms are difficult to control. How often do you feel that your ...
The statistical analysis was performed on the StatView program (version 5.0, SAS Institute Inc., Cary, NC) Results PFS, OS, local tumor control, and prognostic factors At the time of the analysis, 2 patients presented with a radiologic progression (not requiring additional treatment) and 2 ...
The differences between treatments in the distribution of time to rescue were tested using a Wilcoxon test available in SAS statistical software, version 6.12 (SAS LIFETEST; SAS Institute Inc, Cary, NC). The actual remedication times were included in the analysis. Subjects who did not take rescu...
All analyses were conducted using SAS software, version 9.3 (SAS Institute, Cary, NC, USA) and R software version 2.15 (R Foundation for Statistical, Vienna, Austria). Results In our analysis, 146 326 participants contributed 1 805 759 person-years, median (interquartile range, IQR)=...
SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) was used for statistical analyses of safety and efficacy data. Analyses of biomarkers were post hoc and exploratory, with a focus on hypothesis generation. The Kruskal-Wallis rank sum test was used to assess the relationship between ...
Eligible HIV-1-positive antiretroviral therapy (ART)-naïve adults aged 18–65 years were randomly assigned in a 1:1 ratio to receive tenofovir disoproxil fumarate and lamivudine (TDF+3TC) in combination with either ANV (ANV group) or efavirenz (EFV group) for up to 48 weeks. Subsequently...
Primary analyses were performed using SAS version 8 (SAS Institute Inc, Cary, NC). The primary results of this crossover trial derive from an analysis of efficacy on a per protocol basis. Participants qualified for inclusion in the primary analyses if they had measurements of both blood ...
For statistical analyses, we used SAS (SAS release 9.4; SAS Institute Inc, Cary, NC). For the cognitive ancillary substudies, there was no data monitoring committee. This study is registered with ClinicalTrials.gov VITAL-Cog (NCT01669915), VITAL-DEP (NCT01696435) and VITAL (NCT01169259). ...
56,57 Physical abuse and reports of recent victimization are often associated with stress reactions producing anxiety-related problems. Addressing these issues through cognitive-behavioral therapy and psychotropic medications may be useful as violence risk management tactics.58 Targeting dynamic factors with ...
All data analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA). The detailed course after discharge was drawn using the Python Matplotlib package 3.8.3 (Python Software Foundation, Delaware, USA). Ethical Approval This study was approved by the Institutional Review...